Une Nouvelle Revolution Pour le Droit de la Responsabilite? La Gouvernance du Risque Biomedical et L'indemnisation de ses Victimes (A New Revolution for the Law of Civil Liability)
Bibliographic record
Abstract
Biomedical innovation, particularly in pharmacology and medicine, forces the reconsideration of several fundamental principles of the law of civil liability. The uncertainty often affecting the determination of the risks that these innovations pose for human health jeopardizes the capacity of the law of civil liability to compensate its victims and to sanction the behaviours at the source of these risks. This reality has forced the law to re-examine its role in the governance of medical and pharmaceutical activities and in providing adequate support to victims of biomedical developments. A discourse has emerged that pleads for the transformation of private law to allow it-to better contribute to risk prevention. The failings of private law in assisting victims of biomedical risk have also led to the gradual transfer of their compensation to public law. This text studies the influence of precautionary and regulatory objectives on the development and transformation of the law of civil liability in its application to biomedical innovations. It also focuses on the increasing role the State plays in the compensation of injury flowing from the realization of biomedical risks. The exploration of these two tendencies reveals the extent of the contribution of scientific developments in the transformation of the law.L'innovation biomedicale remet en question nombre d'acquis theoriques dans le domaine de la responsabilite civile. L'incertitude entourant la nature et l'etendue des risques que certaines de ces innovations posent pour la sante humaine affecte la capacite du droit de la responsabilite a prendre en charge leurs victimes et a sanctionner les comportements qui sont a leur source. Cette realite force un reexamen du role que joue le droit de la responsabilite civile dans la gouvernance de la prestation medicale et pharmaceutique et la protection des victimes des developpements biomedicaux. Un discours en emergence encourage la transformation du droit prive afin qu'il puisse mieux contribuer a la prevention de ces risques. L'incapacite du droit de la responsabilite a prendre en charge les victimes du risque biomedical a egalement provoque le transfert graduel de leur indemnisation au droit public. Ce texte etudie l'influence des objectifs de precaution et de regulation des risques biomedicaux sur le developpement et la transformation des regles de la responsabilite civile. Il aborde ensuite le role grandissant que l'Etat s'accorde dans l'indemnisation des prejudices causes par la realisation des risques biomedicaux. L'exploration de ces deux tendances revele l'ampleur de la contribution des developpements scientifiques a la transformation du droit.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.014 | 0.015 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.007 | 0.081 |
| Scholarly communication | 0.017 | 0.021 |
| Open science | 0.002 | 0.007 |
| Research integrity | 0.014 | 0.018 |
| Insufficient payload (model declined to judge) | 0.007 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".